Voloridge Investment Management, LLC Revance Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$5.81 - $11.2 $1.58 Million - $3.05 Million	-272,595 Reduced 50.07%	271,852 $2.39 Million
Q3 2023 Nov 14, 2023	BUY	$11.47 - $25.07 $1.3 Million - $2.84 Million	113,351 Added 26.29%	544,447 $6.24 Million
Q2 2023 Aug 14, 2023	BUY	$24.7 - $37.61 $6.57 Million - $10 Million	266,070 Added 161.23%	431,096 $10.9 Million
Q1 2023 May 15, 2023	SELL	$18.36 - $35.27 $1.73 Million - $3.33 Million	-94,427 Reduced 36.39%	165,026 $5.32 Million
Q4 2022 Feb 14, 2023	SELL	$18.32 - $30.66 $5.3 Million - $8.87 Million	-289,154 Reduced 52.71%	259,453 $4.79 Million
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $3.52 Million - $6.99 Million	245,531 Added 81.01%	548,607 $14.8 Million
Q2 2022 Aug 15, 2022	BUY	$11.52 - $20.4 $1.11 Million - $1.96 Million	96,271 Added 46.55%	303,076 $4.19 Million
Q1 2022 May 16, 2022	SELL	$12.36 - $20.31 $151,261 - $248,553	-12,238 Reduced 5.59%	206,805 $4.03 Million
Q4 2021 Feb 14, 2022	BUY	$12.46 - $27.87 $2.73 Million - $6.1 Million	219,043 New	219,043 $3.58 Million
Q2 2020 Aug 14, 2020	SELL	$12.6 - $26.55 $173,338 - $365,248	-13,757 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$12.46 - $27.81 $171,412 - $382,582	13,757 New	13,757 $204,000
Q4 2019 Feb 14, 2020	SELL	$11.66 - $20.15 $227,626 - $393,368	-19,522 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$10.22 - $14.5 $199,514 - $283,069	19,522 New	19,522 $254,000
Q2 2019 Aug 14, 2019	SELL	$10.67 - $15.49 $215,011 - $312,138	-20,151 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$15.4 - $20.39 $310,325 - $410,878	20,151 New	20,151 $318,000

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

Black Rock Inc. New York, NY

8.57M
Shares

$22 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.73M
Shares

$14.7 Million
0.0% of portfolio
Franklin Resources Inc San Mateo, CA

4.78M
Shares

$12.3 Million
0.0% of portfolio
Fil LTD Hamilton, D0

4.19M
Shares

$10.8 Million
0.01% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

4.16M
Shares

$10.7 Million
0.49% of portfolio

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account